This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Endometriosis and infertility treatment

Authoring team

Excision or ablation of endometriosis plus adhesiolysis should be offered for endometriosis not involving the bowel, bladder or ureter, because this improves the chance of spontaneous pregnancy

Laparoscopic ovarian cystectomy with excision of the cyst wall, or laparoscopic drainage and ablation - should be offered to women or people with endometriomas, because this improves the chance of spontaneous pregnancy. Take into account:

  • the possible impact on ovarian reserve
  • that ablation and drainage may preserve ovarian reserve more than cystectomy

Discuss the benefits and risks of laparoscopic surgery as a treatment option with women or people who have deep endometriosis (including endometriosis that involves the bowel, bladder or ureter) and who are trying to conceive so they can make an informed decision on its use. Topics to discuss may include:

  • possible impact of deep endometriosis on pregnancy outcomes
  • whether laparoscopic surgery may alter the chance of future pregnancy
  • possible impact on fertility if complications arise
  • alternatives to surgery
  • other fertility factors

Do not offer hormonal treatment alone or in combination with surgery to women or people with endometriosis who are trying to conceive, because it does not improve spontaneous pregnancy rates

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.